Dashboard
Manage Tickers

CERO CERO THERAPEUTICS HOLDINGS,...


$ -0.01 (-11.38 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 608.09 $ -0.24 (-0.04 %)
DIA $ 469.16 $ 0.95 (0.2 %)
SPY $ 669.39 $ 1.41 (0.21 %)
TLT $ 89.56 $ 0.20 (0.22 %)
GLD $ 368.44 $ 0.50 (0.14 %)
$ na
-- x --
-- x --
-- - --
$ 0.06 - $ 0.21
1,667,439
na
595
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CERo Therapeutics Holdings Initiated Secon...
11/05/2025 13:08:12

Core News & Articles
CERo Therapeutics To Present Preclinical D...
11/04/2025 14:11:12

CERo Therapeutics Holdings, Inc., (OTC:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy co...

Core News & Articles
Maxim Group Downgrades CERo Therapeutics H...
11/03/2025 19:07:46

Maxim Group analyst Jason McCarthy downgrades CERo Therapeutics Hldgs (NASDAQ:CERO) from Buy to Hold.

Core News & Articles
CERo Therapeutics Shares To Continue To Tr...
11/03/2025 13:03:29

CERo Therapeutics Holdings, Inc. (OTC:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy com...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 17:07:10

nasdaq-falls-over-1-alphabet-posts-upbeat-earnings
Nasdaq Falls Over 1%; Alphabet Posts Upbea...
10/30/2025 14:01:00

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

Core News & Articles
D. Boral Capital Maintains Buy on CERo The...
10/30/2025 11:48:11

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

why-alphabet-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher By ...
10/30/2025 09:38:55

Core News & Articles
Reported Earlier, CERo Therapeutics Receiv...
10/30/2025 08:28:44

Core News & Articles
D. Boral Capital Maintains Buy on CERo The...
10/22/2025 12:12:41

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

Core News & Articles
CERo Therapeutics Authorizes Investigators...
10/21/2025 12:19:45

Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq complianceSOUTH SAN FRANC...

Core News & Articles
D. Boral Capital Maintains Buy on CERo The...
10/13/2025 14:43:04

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

Core News & Articles
'CERo Therapeutics CEO: We're "open" to ta...
10/10/2025 18:12:38

https://www.axios.com/pro/biotech-deals/2025/10/10/cero-therapeutics-ceo-open-takeover-offers

Core News & Articles
Cero Therapeutics Has Received A Decision ...
09/26/2025 19:59:01

https://register.epo.org/application?number=EP22758100

Core News & Articles
D. Boral Capital Maintains Buy on CERo The...
09/23/2025 11:20:32

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

Core News & Articles
CERo Therapeutics Doses Third Patient In P...
09/22/2025 13:18:07

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional resul...

top-3-health-care-stocks-youll-regret-missing-in-q3
Top 3 Health Care Stocks You'll Regret Mis...
09/09/2025 13:12:17

Core News & Articles
D. Boral Capital Maintains Buy on CERo The...
09/09/2025 12:41:27

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

Core News & Articles
CERo Therapeutics Secures U.S. And Japanes...
09/09/2025 12:18:26

Additional patent granted from the Japanese patent office now results in 20 granted patents and allowed applications covering t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION